Literature DB >> 12145333

Requirement for thyroid hormone receptor beta in T3 regulation of cholesterol metabolism in mice.

Hjalmar Gullberg1, Mats Rudling, Carmen Saltó, Douglas Forrest, Bo Angelin, Björn Vennström.   

Abstract

T3 potently influences cholesterol metabolism through the nuclear thyroid hormone receptor beta (TRbeta), the most abundant TR isoform in rodent liver. Here, we have tested if TRalpha1, when expressed at increased levels from its normal locus, can replace TRbeta in regulation of cholesterol metabolism. By the use of TRalpha2-/-beta-/- animals that overexpress hepatic TRalpha1 6-fold, a near normalization of the total amount of T3 binding receptors was achieved. These mice are similar to TRbeta-/- and TRalpha1-/-beta-/- mice in that they fail to regulate cholesterol 7alpha-hydroxylase expression properly, and that their serum cholesterol levels are unaffected by T3. Thus, hepatic overexpression of TRalpha1 cannot substitute for absence of TRbeta, suggesting that the TRbeta gene has a unique role in T3 regulation of cholesterol metabolism in mice. However, examination of T3 regulation of hepatic target genes revealed that dependence on TRbeta is not general: T3 regulation of type I iodothyronine deiodinase and the low density lipoprotein receptor were partially rescued by TRalpha1 overexpression. These in vivo data show that TRbeta is necessary for the effects of T3 on cholesterol metabolism. That TRalpha1 only in some instances can substitute for TRbeta indicates that T3 regulation of physiological and molecular processes in the liver occurs in an isoform-specific fashion.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12145333     DOI: 10.1210/me.2002-0009

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  39 in total

Review 1.  New insights into regulation of lipid metabolism by thyroid hormone.

Authors:  Xuguang Zhu; Sheue-yann Cheng
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2010-10       Impact factor: 3.243

Review 2.  GC-1: A Thyromimetic With Multiple Therapeutic Applications in Liver Disease.

Authors:  Amedeo Columbano; Grazia Chiellini; Marta Anna Kowalik
Journal:  Gene Expr       Date:  2017-06-13

3.  Hypermetabolism in mice caused by the central action of an unliganded thyroid hormone receptor alpha1.

Authors:  Maria Sjögren; Anneke Alkemade; Jens Mittag; Kristina Nordström; Abram Katz; Björn Rozell; Håkan Westerblad; Anders Arner; Björn Vennström
Journal:  EMBO J       Date:  2007-10-11       Impact factor: 11.598

4.  The thyromimetic T-0681 protects from atherosclerosis.

Authors:  Ivan Tancevski; Andreas Wehinger; Egon Demetz; Julia Hoefer; Philipp Eller; Eva Huber; Ursula Stanzl; Kristina Duwensee; Kristina Auer; Wilfried Schgoer; Volker Kuhn; Catherine Fievet; Frans Stellaard; Mats Rudling; Bernhard Foeger; Josef R Patsch; Andreas Ritsch
Journal:  J Lipid Res       Date:  2008-12-22       Impact factor: 5.922

5.  Mouse betaine-homocysteine S-methyltransferase deficiency reduces body fat via increasing energy expenditure and impairing lipid synthesis and enhancing glucose oxidation in white adipose tissue.

Authors:  Ya-Wen Teng; Jessica M Ellis; Rosalind A Coleman; Steven H Zeisel
Journal:  J Biol Chem       Date:  2012-02-23       Impact factor: 5.157

6.  Thyroid Hormone Receptor-β Agonist GC-1 Inhibits Met-β-Catenin-Driven Hepatocellular Cancer.

Authors:  Elisabetta Puliga; Qian Min; Junyan Tao; Rong Zhang; Tirthadipa Pradhan-Sundd; Minakshi Poddar; Sucha Singh; Amedeo Columbano; Jinming Yu; Satdarshan P Monga
Journal:  Am J Pathol       Date:  2017-08-12       Impact factor: 4.307

7.  Thyroid hormone induction of human cholesterol 7 alpha-hydroxylase (Cyp7a1) in vitro.

Authors:  Jan A Lammel Lindemann; Anusha Angajala; David A Engler; Paul Webb; Stephen D Ayers
Journal:  Mol Cell Endocrinol       Date:  2014-02-25       Impact factor: 4.102

8.  Adipogenesis is differentially impaired by thyroid hormone receptor mutant isoforms.

Authors:  Alok Mishra; Xu-Guang Zhu; Kai Ge; Sheue-Yann Cheng
Journal:  J Mol Endocrinol       Date:  2010-01-15       Impact factor: 5.098

9.  Thyroid hormone beta receptor activation has additive cholesterol lowering activity in combination with atorvastatin in rabbits, dogs and monkeys.

Authors:  B R Ito; B-H Zhang; E E Cable; X Song; J M Fujitaki; D A MacKenna; C E Wilker; B Chi; P D van Poelje; D L Linemeyer; M D Erion
Journal:  Br J Pharmacol       Date:  2009-01-22       Impact factor: 8.739

10.  The thyroid hormone mimetic compound KB2115 lowers plasma LDL cholesterol and stimulates bile acid synthesis without cardiac effects in humans.

Authors:  Anders Berkenstam; Jens Kristensen; Karin Mellström; Bo Carlsson; Johan Malm; Stefan Rehnmark; Neeraj Garg; Carl Magnus Andersson; Mats Rudling; Folke Sjöberg; Bo Angelin; John D Baxter
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-26       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.